The New Oncologic Diagnosis Discussion: Perspectives of Pediatric Oncologists
JCO Oncology Practice · 2023
DOI: 10.1200/op.22.00558 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2023. Verfasst von Kathryn A Six und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Outcomes and Survivorship, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL. Hauptthemen laut MEDLINE: Neoplasms, Oncologists. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We aimed to understand how new diagnosis discussions are conducted in pediatric oncology, and the training provided for their conduct. METHODS: This mixed-methods study used a sequential exploratory design. Qualitative interviews (n = 20) were conducted with pediatric oncologists (n = 15) and fellows (n = 5) at a single institution, focusing on the process used to convey the diagnosis and treatment plan to the family. Accreditation Council for Graduate Medical Education–accredited pediatric oncology fellowship program directors (n = 38) and fellows (n = 70) were subsequently surveyed to confirm qualitative results and elucidate the training that fellows receive in conducting new diagnosis discussions. RESULTS: Our findings suggest that new diagnosis discussions in pediatric oncology are typically conducted in three stages: (1) concern for cancer; (2) confirmation of diagnosis; and (3) treatment plan/consent, and are fundamentally similar across settings; however, pediatric oncologists skillfully tailor their approach on the basis of clinical circumstances and parental needs. Decisions regarding inclusion of the child are primarily determined by parental preference, whereas inclusion of health care team members is driven by physician role (ie, trainee v program director) and health care organization–related factors. Physician preparation for discussions involves logistical, intellectual, and emotional components. Disclosure of prognosis is nuanced. There is variability across pediatric oncology fellowship programs in the provision of training for these discussions. CONCLUSION: We identified common practices of pediatric oncologists as they prepare for and lead new diagnosis discussions in pediatric oncology. We found variability in the training that pediatric oncology fellows receive regarding how to conduct these discussions, highlighting a need for standardized training curricula.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Cancer Outcomes and Survivorship, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
- Division of Pediatric Hematology/Oncology, Department of Pediatrics, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
- Atrium Health Levine Children's Cancer and Blood Disorders, Wake Forest University School of Medicine, Charlotte, NC.
ORCID-Profile: Kathryn A Six, Kandice Adams, Smita Bhatia, Wendy Landier
Zitieren
APA
Six, K. A., Wadhwa, A., York, J. M., Adams, K., Henneberg, H., Bhatia, S., & Landier, W. (2023). The New Oncologic Diagnosis Discussion: Perspectives of Pediatric Oncologists. JCO Oncology Practice. https://doi.org/10.1200/op.22.00558
Vancouver
Six KA, Wadhwa A, York JM, Adams K, Henneberg H, Bhatia S, et al. The New Oncologic Diagnosis Discussion: Perspectives of Pediatric Oncologists. JCO Oncology Practice. 2023. doi:10.1200/op.22.00558
BibTeX
@article{Six2023,
author = {Six, Kathryn A and Wadhwa, Aman and York, Jocelyn M and Adams, Kandice and Henneberg, Harrison and Bhatia, Smita and Landier, Wendy},
title = {The New Oncologic Diagnosis Discussion: Perspectives of Pediatric Oncologists},
journal = {JCO Oncology Practice},
year = {2023},
doi = {10.1200/op.22.00558}
}
EUVIMED